ANI Pharmaceuticals director Henry O. Gosebruch files initial beneficial ownership statement (Form 3)
ANIP•Form 3 filing for director Henry O. Gosebruch
- ANI Pharmaceuticals filed a Form 3 showing director Henry O. Gosebruch as a reporting insider as of Aug. 19, 2026.




